Scarica l'app Stockscreener
91.95
2.06%
1.85
Dopo l'orario di chiusura:
91.95
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$90.10
Aprire:
$90.28
Volume 24 ore:
270.73K
Relative Volume:
0.59
Capitalizzazione di mercato:
$1.99B
Reddito:
$486.82M
Utile/perdita netta:
$18.78M
Rapporto P/E:
112.13
EPS:
0.82
Flusso di cassa netto:
$100.45M
1 W Prestazione:
+1.30%
1M Prestazione:
-5.73%
6M Prestazione:
+32.89%
1 anno Prestazione:
+54.14%
Intervallo 1D:
$90.28
$92.26
Intervallo di 1 settimana:
$87.60
$92.26
Portata 52W:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Nome
Ani Pharmaceuticals Inc
Settore
Telefono
(218) 634-3500
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Confronta ANIP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
91.95 | 1.98B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
143.24 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.89 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.185 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.62 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.69 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-03-12 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Iniziato | Leerink Partners | Outperform |
| 2024-10-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-15 | Iniziato | CapitalOne | Overweight |
| 2023-08-22 | Reiterato | H.C. Wainwright | Buy |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-02 | Iniziato | Truist | Buy |
| 2020-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-05-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Reiterato | Canaccord Genuity | Buy |
| 2017-07-31 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-22 | Downgrade | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Iniziato | Raymond James | Strong Buy |
| 2016-05-24 | Downgrade | Standpoint Research | Buy → Hold |
| 2015-11-13 | Iniziato | Standpoint Research | Buy |
| 2015-09-28 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Reiterato | Oppenheimer | Outperform |
| 2015-08-04 | Reiterato | ROTH Capital | Neutral |
| 2015-07-31 | Reiterato | Oppenheimer | Outperform |
| 2015-07-15 | Reiterato | ROTH Capital | Neutral |
| 2015-06-23 | Reiterato | Oppenheimer | Outperform |
| 2015-05-18 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Reiterato | Oppenheimer | Outperform |
| 2015-04-10 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Reiterato | ROTH Capital | Buy |
| 2015-02-18 | Reiterato | Oppenheimer | Outperform |
Mostra tutto
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
How ANI Pharmaceuticals Inc. stock trades during market volatilityJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
What indicators show strength in ANI Pharmaceuticals Inc.Day Trade & Weekly Market Pulse Updates - newser.com
How ANI Pharmaceuticals Inc. (BSFA) stock compares with tech leadersQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
Regression analysis insights on ANI Pharmaceuticals Inc. performanceQuarterly Profit Report & Stepwise Entry/Exit Trade Alerts - newser.com
Ani Pharmaceuticals’ cook sells $36k in stock By Investing.com - Investing.com South Africa
Ani Pharmaceuticals’ cook sells $36k in stock - Investing.com
Assessing Valuation: ANI Pharmaceuticals (ANIP) Up 60% Year-to-Date—Is the Market Overlooking Growth? - Yahoo Finance
ANI Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Published on: 2025-10-14 15:05:19 - newser.com
ANI Pharmaceuticals Inc. stock trend forecastWatch List & Verified Momentum Stock Alerts - newser.com
Has ANI Pharmaceuticals Inc. formed a bullish divergenceWeekly Investment Recap & Community Verified Trade Alerts - newser.com
Can ANI Pharmaceuticals Inc. stock deliver strong Q4 earnings2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com
What moving averages say about ANI Pharmaceuticals Inc.2025 Earnings Impact & Reliable Trade Execution Plans - newser.com
Published on: 2025-10-13 10:59:38 - newser.com
Is ANI Pharmaceuticals Inc. a candidate for recovery play2025 Earnings Impact & Short-Term High Return Ideas - newser.com
Analyzing recovery setups for ANI Pharmaceuticals Inc. investorsGap Up & Real-Time Buy Signal Alerts - newser.com
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - sharewise.com
Truist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price - MarketBeat
Visualizing ANI Pharmaceuticals Inc. stock with heatmaps2025 Price Targets & Weekly High Momentum Picks - newser.com
What recovery options are there for ANI Pharmaceuticals Inc.Portfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Will a bounce in ANI Pharmaceuticals Inc. offer an exitQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock beat value stocksQuarterly Profit Report & Pattern Based Trade Signal System - newser.com
Is ANI Pharmaceuticals Inc. stock undervalued vs historical averages2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com
ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings - MarketBeat
ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q2 Earnings? - Barchart.com
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q2 Earnings? - FinancialContent
Institutional scanner results for ANI Pharmaceuticals Inc.Bond Market & Low Drawdown Trading Strategies - newser.com
Can ANI Pharmaceuticals Inc. stock sustain revenue growth2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Live market analysis of ANI Pharmaceuticals Inc.Weekly Gains Summary & Technical Buy Zone Confirmations - newser.com
Is a relief rally coming for ANI Pharmaceuticals Inc. holdersWeekly Investment Report & Weekly Top Gainers Alerts - newser.com
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ani Pharmaceuticals Inc Azioni (ANIP) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Davis Krista | SVP, CHIEF HR OFFICER |
Sep 19 '25 |
Sale |
98.04 |
1,000 |
98,040 |
60,186 |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. |
Sep 12 '25 |
Sale |
98.42 |
400 |
39,368 |
76,074 |
| Pera Antonio R | Director |
Sep 03 '25 |
Sale |
94.94 |
7,292 |
692,302 |
22,660 |
0.02%
5.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):